Presentation Information
[3P-765]β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus
○Kei Konishi1,2, Shinji Kusakabe1,2, Nijiho Kawaguchi1, Takao Shishido2, Naoto Ito3, Yasuko Orba1,4,5, Hirofumi Sawa1,4,5, Michihito Sasaki1,4, Akihiko Sato1,2,4 (1. International Institute for Zoonosis Control, Hokkaido University, 2. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd, 3. Faculty of Applied Biological Sciences, Gifu University, 4. Institute for Vaccine Research and Development, Hokkaido University, 5. One Health Research Center, Hokkaido University)
Password required to view
orLog in
Comment
To browse or post comments, you must log in.Log in